remdesivir

Hetero expects to make the treatment, tocilizumab, available in India by the end of the month under the brand name Tocira

Raw materials for the drugs are available in enough quantities

ACTIV-3 Critical Care is evaluating Zyesami and Remdesivir in critical COVID-19 patients as monotherapy, and in combination…

The availability of all major drugs required for the management of COVID-19 was regularly monitored through weekly surveys of…

The authority fixes the ceiling prices of scheduled formulations as per the provisions of DPCO, 2013, and monitors the prices of…

BDR Pharma will be manufacturing and marketing the product under a royalty-free, limited and non-exclusive voluntary licence from…

Dr Arun Bhatt, Consultant – Clinical Research & Drug Development states that in the absence of a peer-reviewed publication in…

Rev. Jackson will be joined by a number of prominent Indian leaders in Washington to make a public appeal to Biden for more…

With the accelerated approval of 38 additional manufacturing sites, the number of approved manufacturing sites of remdesivir in…

The Centre said that the DCGI has instructed the state governments that there should be zero tolerance to any kind of hoarding or…